Wixela Inhub Alternatives in North Dakota
Compare generic and therapeutic alternatives to Wixela Inhub (fluticasone propionate / salmeterol (generic Advair Diskus)) available at North Dakota pharmacies. Save up to 73% on your prescription — no insurance required.
Top Alternatives in North Dakota
Advair Diskus (brand fluticasone/salmeterol)
brand
Reference brand — identical drug at 3-4× the cost
Avg cash price: $450/mo
Symbicort (budesonide/formoterol)
therapeutic
Different ICS/LABA molecules — no generic as of 2025
Avg cash price: $380/mo
Breo Ellipta (fluticasone furoate/vilanterol)
therapeutic
Once-daily ICS/LABA — once daily
Avg cash price: $420/mo
North Dakota Prescription Assistance Programs
North Dakota Medicaid Rx
Prescription drug coverage for North Dakota Medicaid beneficiaries.
Eligibility: Low-income North Dakota adults, children, pregnant women, and people with disabilities meeting eligibility requirements.
Frequently Asked Questions
Is Wixela Inhub a true generic for Advair?
Yes — Wixela Inhub (fluticasone propionate/salmeterol) is the FDA-approved generic for Advair Diskus. It is the first and most affordable generic ICS/LABA combination inhaler available in the US.
How much cheaper is Wixela compared to Advair?
Wixela Inhub typically costs $100–$140/month versus $400–$470 for brand Advair Diskus — a saving of 65–75%. It is the same drug in the same inhaler device format.
Can I substitute Wixela for Advair without asking my doctor?
As an FDA-approved generic, Wixela can often be automatically substituted by a pharmacist. However, confirm with your prescriber if you have COPD or severe asthma requiring precise dosing.
Is Wixela available in all the same strengths as Advair?
Wixela Inhub is available in all three Advair Diskus strengths: 100/50, 250/50, and 500/50 mcg (fluticasone/salmeterol). Advair HFA (metered dose inhaler) has a different generic — AirDuo RespiClick.
Can Script Unlock help me access Wixela at the best price?
Yes — Wixela Inhub is widely available through Script Unlock pharmacies. Competitive bidding frequently produces cash prices well below chain pharmacy pricing for this popular generic inhaler.